Nexalis Therapeutics Limited has released a press release.
Non-renounceable rights issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Story so far
Earlier from Nexalis Therapeutics
- $720,500 Private Placement
- Quarter 3 Update
- Pause in Trading
- CEO appointment
- Reinstatement to Official Quotation
Later from Nexalis Therapeutics
- Rights Issue Offer Document
- Placement of Rights Issue Shortfall
- Quarter 4 Update
- Quarter 1 Update
- Appendix 4C - quarterly
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics